The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Inflammatory Cytokines in Diabetic Nephropathy
Open accessAbstract
Probably, the most paradigmatic example of diabetic complication is diabetic nephropathy, which is the largest single cause of end-stage renal disease and a medical catastrophe of worldwide dimensions. Metabolic and hemodynamic alterations have been considered as the classical factors involved in the development of renal injury in patients with diabetes mellitus. However, the exact pathogenic mechanisms and the molecular events of diabetic nephropathy remain incompletely understood. Nowadays, there are convincing data that relate the diabetes inflammatory component with the development of renal disease. This review is focused on the inflammatory processes that develop diabetic nephropathy and on the new therapeutic approaches with anti-inflammatory effects for the treatment of chronic kidney disease in the setting of diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Self-citationTumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.
Laster, S. M., Wood, J. G., & Gooding, L. R. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2629 · Cited by 903
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Pathogenetic Mechanisms of Diabetic Nephropathy
Schena, F. P., & Gesualdo, L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110970 · Cited by 589
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Han, J., Thompson, P., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.391 · Cited by 508
Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., et al. (2015) · Kidney International · doi:10.1038/ki.2014.271 · Cited by 411
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
Dandona, P., Dhindsa, S., Ghanim, H., & Chaudhuri, A. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002101 · Cited by 386
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Jeffcoate, W. J., Game, F., & Cavanagh, P. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67029-8 · Cited by 373
Festa, A., D'agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00331.x · Cited by 369
Dong, X., Swaminathan, S., Bachman, L.-A., Croatt, A.-J., Nath, K.-A., & Griffin, M.-D. (2007) · Kidney International · doi:10.1038/sj.ki.5002132 · Cited by 363
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Salt Induces Myocardial and Renal Fibrosis in Normotensive and Hypertensive Rats
Yu, H. C. M., Burrell, L. M., Black, M. J., Wu, L. L., Dilley, R. J., Cooper, M. E., & Johnston, C. I. (1998) · Circulation · doi:10.1161/01.cir.98.23.2621 · Cited by 344
Melnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
Macrophage accumulation in human progressive diabetic nephropathy
NGUYEN, D., PING, F., MU, W., HILL, P., ATKINS, R. C., & CHADBAN, S. J. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00576.x · Cited by 331
The epidemiology of chronic kidney disease
Atkins, R. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09403.x · Cited by 320
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.58 · Cited by 319
Pentoxifylline suppression of tumor necrosis factor gene transcription.
Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1991) · PubMed · Cited by 306
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4618 · Cited by 301
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., & Tesch, G. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070612 · Cited by 277
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Tumor necrosis factor induces glomerular damage in the rabbit.
Bertani, T., Abbate, M., Zoja, C., Corna, D., Perico, N., Ghezzi, P., & Remuzzi, G. (1989) · Europe PMC (PubMed Central) · Cited by 246
Gullestad, L., Aukrust, P., Ueland, T., Espevik, T., Yee, G., Vagelos, R., Frøland, S. S., & Fowler, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00495-7 · Cited by 240
Navarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238
Adipokines, inflammation, and the endothelium in diabetes
Aldhahi, W., & Hamdy, O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0020-2 · Cited by 232
McCarthy, E. T., Sharma, R., Sharma, M., Li, J. Z., Ge, X. L., Dileepan, K. N., & Savin, V. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93433 · Cited by 231
Role of inflammation in diabetic complications
Navarro, J. F., & Mora, C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi155 · Cited by 227
Navarro-González, J. F., Mora-Fernández, C., Muros de Fuentes, M., Chahin, J., Méndez, M. L., Gallego, E., Macía, M., del Castillo, N., Rivero, A., Getino, M. A., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010012 · Cited by 221
Self-citationNavarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2890 · Cited by 218
Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammatory Disease
Tuttle, K. R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040393 · Cited by 216
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini, R., Velussi, M., Brocco, E., Bruseghin, M., Abaterusso, C., Saller, A., Dalla Vestra, M., Carraro, A., Bortoloso, E., Sambataro, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.476 · Cited by 202
Boyle, J. J., Weissberg, P. L., & Bennett, M. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000086961.44581.b7 · Cited by 197
Pfeilschifter, J., Pignat, W., Vosbeck, K., & Märki, F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90003-x · Cited by 191
IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor
Fantuzzi, G., Reed, D. A., & Dinarello, C. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7501 · Cited by 189
Inflammation and diabetic nephropathy
Mora, C., & Navarro, J. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0080-1 · Cited by 183
Type 2 diabetes mellitus: a disease of the innate immune system? An update
Crook, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01030.x · Cited by 179
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Prevention of End-Stage Renal Disease Due to Type 2 Diabetes
Hostetter, T. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451209 · Cited by 169
Stimulated kidney tubular epithelial cells express membrane associated and secreted TNFα
Jevnikar, A. M., Brennan, D. C., Singer, G. G., Heng, J. E., Maslinski, W., Wuthrich, R. P., Glimcher, L. H., & Kelley, V. E. (1991) · Kidney International · doi:10.1038/ki.1991.201 · Cited by 154
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
DiPetrillo, K., Coutermarsh, B., & Gesek, F. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2002 · Cited by 154
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 152
Lee, F., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 150
Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & García, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 144
Self-citationNavarro‐González, J. F., Fernández, C. M., Rivero, A., Gallego, E., Chahin, J., Macia, M. L., Méndez, M. L., & García, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70182-4 · Cited by 143
Self-citationInterleukin-6: An autocrine regulator of mesangial cell growth
COLEMAN, D. L., & Ruef, C. (1992) · Kidney International · doi:10.1038/ki.1992.91 · Cited by 137
Nakagawa, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2006 · Cited by 134
Increased Levels of C-Reactive Protein in Noncontrolled Type II Diabetic Subjects
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00047-1 · Cited by 126
Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury
Awad, A. S., Kinsey, G. R., Khutsishvili, K., Gao, T., Bolton, W. K., & Okusa, M. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00332.2011 · Cited by 124
Navarro‐González, J. F., Fernández, C. M., Muros, M., & García, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl469 · Cited by 122
Self-citationNavarro‐González, J. F., Mora, C., Muros, M., & Garcı́a, J. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010001 · Cited by 121
Self-citationProgression to Overt Nephropathy in Type 2 Diabetes
Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Pagano, G., & Perin, P. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2150 · Cited by 118
Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure?
Stenvinkel, P., Andersson, P., Wang, T., Lindholm, B., Bergström, J. P., Palmblad, J. E. W., Heimbürger, O., & Cederholm, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00560.x · Cited by 118
Schindler, R., Dinarello, C. A., & Koch, K.-M. (1995) · Cytokine · doi:10.1006/cyto.1995.0071 · Cited by 118
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 116
The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
McCormick, B. B., Sydor, A., Akbari, A., Fergusson, D. A., Doucette, S. P., & Knoll, G. A. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.025 · Cited by 115
Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110
Skundric, D. S., & Lisak, R. P. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.303 · Cited by 110
Diabetic kidney disease: act now or pay later
Atkins, R. C., & Zimmet, P. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.10 · Cited by 108
Baud, L., Perez, J., Friedlander, G., & Ardaillou, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80543-x · Cited by 105
Jones, S. G., Jones, S., & Phillips, A. O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051739.x · Cited by 104
Koike, N., Takamura, T., & Kaneko, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.001 · Cited by 103
Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.
Moriyama, T., Fujibayashi, M., Fujiwara, Y., Kaneko, T., Xia, C., Imai, E., Kamada, T., Ando, A., & Ueda, N. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v6195 · Cited by 103
The effect of renin–angiotensin system inhibitors on pro‐ and anti‐inflammatory cytokine production
Peeters, A. C. T. M., Netea, M. G., Kullberg, B. J., Thien, T., & van der Meer, J. W. M. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00524.x · Cited by 98
Cooper, A. C., Mikhail, A. I., Lethbridge, M. W., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131523.17045.56 · Cited by 95
Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions
Dagenais, N. J., & Jamali, F. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1213 · Cited by 94
Inflammatory Cells in Renal Injury and Repair
Ferenbach, D. A., Kluth, D., & Hughes, J. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.001 · Cited by 91
Dai, S., Matsuno, H., Nakamura, H., Nishioka, K., & Yudoh, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20064 · Cited by 89
Miyauchi, K., Takiyama, Y., Honjo, J., Tateno, M., & Haneda, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.018 · Cited by 88
DiPetrillo, K., & Gesek, F. A. (2004) · American Journal of Nephrology · doi:10.1159/000079121 · Cited by 87
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Kitching, A. R., Thomas, M. C., & Tesch, G. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1757-1 · Cited by 82
Tumor necrosis factor alpha and mesangial cells
Baud, L., Fouqueray, B. L., Philippe, C., & Amrani, A. (1992) · Kidney International · doi:10.1038/ki.1992.90 · Cited by 81
Martini, S., Eichinger, F. H., Nair, V., & Kretzler, M. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9103-3 · Cited by 76
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
Mariño, E., & Cardier, J. E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00150-9 · Cited by 70
Ortiz, L. A., Champion, H. C., Lasky, J. A., Gambelli, F., Gozal, E., Hoyle, G. W., Beasley, M. B., Hyman, A. L., Friedman, M. B., & Kadowitz, P. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2001 · Cited by 68
Raised Serum Sialic Acid Concentration in NIDDM Patients With and Without Diabetic Nephropathy
Chen, J., Gall, M.-A., Yokoyama, H., Jensen, J. S., Deckert, M., & Parving, H. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.130 · Cited by 67
Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
Guerrero‐Romero, F., Rodríguez‐Morán, M., Paniagua-Sierra, J. R., García-Bulnes, G., Salas-Ramírez, M., & Amato, D. (1995) · PubMed · Cited by 65
Moriya, R., Manivel, J. C., & Mauer, M. S. (2004) · Diabetologia · doi:10.1007/s00125-003-1253-y · Cited by 64
Stuyt, R. J. L., Netea, M. G., Geijtenbeek, T. B. H., Kullberg, B. J., Dinarello, C. A., & van der Meer, J. W. M. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01747.x · Cited by 64
Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats
Voisin, L., Breuillé, D., Ruot, B., Rallière, C., Rambourdin, F., Dalle, M., & Obled, C. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.5.r1412 · Cited by 64
Mahadevan, P., Larkins, R. G., Fraser, J. R. E., Fosang, A., & Dunlop, M. (1995) · Diabetologia · doi:10.1007/bf00400634 · Cited by 60
Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes
Schreiner, G. F., & Kohan, D. E. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.4.f761 · Cited by 58
Role of Macrophages in the Pathogenesis of Diabetic Nephropathy
Shikata, K., & Makino, H. (2001) · KARGER eBooks · doi:10.1159/000060147 · Cited by 53
Diabetic kidney disease: act now or pay later
Atkins, R. C., & Zimmet, P. (2010) · Kidney International · doi:10.1038/ki.2009.509 · Cited by 53
Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases.
Egido, J., Marta Gómez-chiarri, G., Ortíz, A., Bustos, C., Alonso, J., Gómez‐Guerrero, C., Gómez‐Garré, D., López-Armada, M. J., Plaza, J. J. G., & Gonzalez, E. (1993) · PubMed · Cited by 52
Inflammation and pathogenesis of diabetic nephropathy
Mora, C., & Navarro‐González, J. F. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.005 · Cited by 51
Self-citationRodríguez‐Morán, M., González-González, G. M., Bermúdez-Barba, M. V., Garza, C., Tamez-Pérez, H. E., Martínez-Martínez, F. J., & Guerrero‐Romero, F. (2006) · Clinical Nephrology · doi:10.5414/cnp66003 · Cited by 45
Treating diabetic nephropathy—still an unresolved issue
Cooper, M. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.125 · Cited by 44
IFNγ induces functional chemokine receptor expression in human mesangial cells
Schwarz, M., WAHL, M., Resch, K., & Radeke, H. H. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01829.x · Cited by 40
Reduction of Macroalbuminuria With Pentoxifylline in Diabetic Nephropathy: Report of three cases
Gorson, D. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2190b · Cited by 36
Flyvbjerg, A., Khatir, D. S., Jensen, L., Dagnæs‐Hansen, F., Grønbæk, H., & Rasch, R. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383106 · Cited by 34
Tissue factor regulation and cytokine expression in monocyte–endothelial cell co-cultures
Lindmark, E., & Siegbahn, A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00401-2 · Cited by 32
The next generation of diabetic nephropathy therapies: An update
Williams, M. E., & Tuttle, K. R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.011 · Cited by 30
Pfeilschifter, J., & Mühl, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90371-s · Cited by 26
Monocyte chemotactic peptide-1 in diabetic nephropathy.
Ihm, C. G. (1997) · PubMed · Cited by 21
Efecto de la pentoxifilina sobre la evolución de la nefropatía diabética
Leyva-Jiménez, R., Rodríguez-Orozco, A. R., Ortega-Pierres, L. E., Ramírez-Enríquez, J., Gómez‐García, A., & Álvarez-Aguilar, C. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.05.024 · Cited by 18
Cited by
Li, Y. J., Chen, X., Kwan, T. K., Loh, Y. W., Singer, J., Liu, Y., Ma, J., Tan, J., Macia, L., Mackay, C. R., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101029 · Cited by 368
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.023 · Cited by 297
Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney
Nastase, M. V., Zeng-Brouwers, J., Beckmann, J., Tredup, C., Christen, U., Radeke, H. H., Wygrecka, M., & Schaefer, L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.002 · Cited by 60
Raghav, A., Ahmad, J., & Alam, K. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.07.033 · Cited by 15
Metadata
- Authors
- Donate-Correa, J., Martín-Núñez, E., Muros-de-Fuentes, M., Mora-Fernández, C., & Navarro-González, J. F.
- Venue
- Journal of Diabetes Research
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-9
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2026672268
- Cited by
- 277
- References
- 116
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.